CTO PCI: an evolving landscape

Session comprising selected EuroPCR 2026 abstract submissions

Moderators: A. Elguindy, J. Davies

Summary

Review the evolving landscape of chronic total occlusion (CTO) PCI with a focus on recent trends, contemporary management in multivessel disease, and innovative techniques such as retrograde approaches and titrated contrast recanalization. This session also addresses cost-effectiveness and drug-coated balloon (DCB) therapy outcomes from multicenter studies.

Presentations available when logged in:

  • Contemporary management of CTO in the setting of de novo three vessel disease
  • Externalisation versus portal techniques in retrograde chronic total occlusion percutaneous coronary
  • Cost-effectiveness of percutaneous revascularisation of coronary CTO in Sweden
  • DCB for CTO: final results of PICCOLETO X multicentre study
  • Titrated contrast recanalisation: a novel controlled-contrast technique for antegrade CTO crossing